Alisar S. Zahr is the Director of Research and Clinical Development at Revision Skincare. She is responsible for conducting studies for new trial launches at Revision’s Skincare, and following research & development of a product through its lifespan. Alisar received her PhD at Penn State in chemical engineering, specifically in designing drug delivery systems to treat cancer. This led her to Harvard to complete a post doctorate program for ophthalmology, where she published and patented technology in molecular biology.
Part One: Alisar S. Zahr is the director of Research and Clinical Development at Revisions Skincare. In today’s episode we will catch up with Alisar and learn about an exciting new category in skincare. We will discuss Revisions Skincare’s launch of their new product and the role Alisar played in bringing it to the market. This new product will make us look at sunflower seeds in a whole new light. Tune in to find out what type of product can make 100% of people in a clinical study see significant difference!